William Blair Says Cash Is King In Salix Bidding War

By: via Benzinga
Valeant Pharmaceuticals Intl Inc (NYSE: VRX) is likely to prevail over a newly emerged rival in its bid to acquire Salix ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.